Article Versions Notes

Ting W-H, Hsiao C-H, Chen H-H, Wei M-C, Lin H-H, Hsiao S-M. Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal versus Dose-Dense Platinum/Paclitaxel Chemotherapy without Bevacizumab. International Journal of Environmental Research and Public Health. 2020; 17(10):3603. https://doi.org/10.3390/ijerph17103603

Ting, Wan-Hua, Chi-Huang Hsiao, Hui-Hua Chen, Ming-Chow Wei, Ho-Hsiung Lin, and Sheng-Mou Hsiao. 2020. "Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal versus Dose-Dense Platinum/Paclitaxel Chemotherapy without Bevacizumab" International Journal of Environmental Research and Public Health 17, no. 10: 3603. https://doi.org/10.3390/ijerph17103603

Ting, W.-H., Hsiao, C.-H., Chen, H.-H., Wei, M.-C., Lin, H.-H., & Hsiao, S.-M. (2020). Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal versus Dose-Dense Platinum/Paclitaxel Chemotherapy without Bevacizumab. International Journal of Environmental Research and Public Health, 17(10), 3603. https://doi.org/10.3390/ijerph17103603